secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001628280-25-048251
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q3 revenue down 36% to $89.4M; net loss $2.3M; coaches drop 35%
------------------------------------------------------------------------

- Revenue $89.4M vs $140.2M YoY; net loss $0.21 per diluted share vs $0.10 income.
- Active earning OPTAVIA coaches fell to 19,500 from 30,000, due to GLP-1 competition.
- Gross margin 69.5% vs 75.4% on fixed-cost de-leverage and $180 basis pts for product reformulation.
- Q4 2025 guidance: revenue $65M–$80M; diluted loss per share $0.70–$1.25.
- Cash & investments $173.5M; no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/0001628280-25-048251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/med-20251103.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-048251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer